Signalling via the hypoxia-inducible factor-1α requires multiple posttranslational mofications

被引:174
|
作者
Brahimi-Horn, C [1 ]
Mazure, N [1 ]
Pouysségur, J [1 ]
机构
[1] CNRS, Inst Signaling Dev Biol & Canc Res, CNRS, UMR 6543,Ctr A Lacassagne, F-06189 Nice, France
关键词
angiogenesis; arrest defective-protein; cancer; hypoxia; hypoxia-inducible factor; posttranslational modification; prolyl-4-hydroxylase;
D O I
10.1016/j.cellsig.2004.04.010
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cellular hypoxia, a local decrease in the oxygen concentration below normal (21%) atmospheric concentrations, occurs in both physiological and pathological situations. The transcriptional complex Hypoxia-Inducible Factor-1 (HIF-1) is the key player in the signalling pathway that controls the hypoxic response of mammalian cells. Tight regulation of this response involves posttranslational modification of the alpha subunit of HIF-1. Hydroxylation, ubiquitination, acetylation, S-nitrosation and phosphorylation have been shown to determine its half-life and/or transcriptional activity. The precise spatio-temporal occurrence of these multiple modifications is still not fully understood but is dependent on the microenvironment and determines the driving force of variable cellular responses. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [31] Tetrathiomolybdate mediates the degradation of hypoxia-inducible factor-1α
    Kim, Kyu Kwang
    Abelman, Sarah
    Yano, Naohiro
    Ribeiro, Jennifer R.
    Singh, Rakesh K.
    Tipping, Marla
    Moore, Richard G.
    GYNECOLOGIC ONCOLOGY, 2015, 139 (03) : 590 - 590
  • [32] Living kidney donors and hypoxia-inducible factor-1α
    Baan, C
    van Gelder, T
    Peeters, A
    Mol, W
    Niesters, H
    Weimar, W
    IJzermans, J
    TRANSPLANTATION, 2003, 75 (04) : 570 - 571
  • [33] Hypoxia-inducible factor-1 regulation of myeloid cells
    Stothers, C. L.
    Luan, L.
    Fensterheim, B. A.
    Bohannon, J. K.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2018, 96 (12): : 1293 - 1306
  • [34] The Role of Hypoxia-inducible Factor-1 in Bladder Cancer
    Chai, Jiagui
    Yin, Sifan
    Feng, Wenbo
    Zhang, Tao
    Ke, Changxing
    CURRENT MOLECULAR MEDICINE, 2024, 24 (07) : 827 - 834
  • [35] Targeting hypoxia-inducible factor-1 for therapy and prevention
    Zhong, H
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (07) : 951 - 966
  • [36] A role for hypoxia-inducible factor-1α in desferoxamine neuroprotection
    Hamrick, SEG
    McQuillen, PS
    Jiang, XN
    Mu, DZ
    Madan, A
    Ferriero, DM
    NEUROSCIENCE LETTERS, 2005, 379 (02) : 96 - 100
  • [37] Hypoxia-Inducible Factor-1α and Autoimmune Lupus, Arthritis
    Zu-Cheng Yang
    Yi Liu
    Inflammation, 2016, 39 : 1268 - 1273
  • [38] The Role of Hypoxia-Inducible Factor-1α in Acetaminophen Hepatotoxicity
    Sparkenbaugh, Erica M.
    Saini, Yogesh
    Greenwood, Krista K.
    LaPres, John J.
    Luyendyk, James P.
    Copple, Bryan L.
    Maddox, Jane F.
    Ganey, Patricia E.
    Roth, Robert A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (02): : 492 - 502
  • [39] Copper Regulation of Hypoxia-Inducible Factor-1 Activity
    Feng, Wenke
    Ye, Fei
    Xue, Wanli
    Zhou, Zhanxiang
    Kang, Y. James
    MOLECULAR PHARMACOLOGY, 2009, 75 (01) : 174 - 182
  • [40] Skeletal muscle hypoxia-inducible factor-1 and exercise
    Lindholm, Malene E.
    Rundqvist, Helene
    EXPERIMENTAL PHYSIOLOGY, 2016, 101 (01) : 28 - 32